Samsara BioCapital’s Nuvation Bio Inc Warrants NUVB.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-124,119
| Closed | -$41K | – | 23 |
|
|
2025
Q4 | $41K | Sell |
124,119
-9,214
| -7% | -$2.02K | ﹤0.01% | 21 |
|
|
2025
Q3 | $26.9K | Hold |
133,333
| – | – | ﹤0.01% | 26 |
|
|
2025
Q2 | $36K | Hold |
133,333
| – | – | 0.01% | 28 |
|
|
2025
Q1 | $42.7K | Hold |
133,333
| – | – | 0.01% | 35 |
|
|
2024
Q4 | $30.7K | Hold |
133,333
| – | – | ﹤0.01% | 42 |
|
|
2024
Q3 | $13.1K | Hold |
133,333
| – | – | ﹤0.01% | 41 |
|
|
2024
Q2 | $21.3K | Hold |
133,333
| – | – | ﹤0.01% | 39 |
|
|
2024
Q1 | $40.3K | Hold |
133,333
| – | – | 0.01% | 38 |
|
|
2023
Q4 | $8K | Hold |
133,333
| – | – | ﹤0.01% | 40 |
|
|
2023
Q3 | $13.3K | Hold |
133,333
| – | – | ﹤0.01% | 40 |
|
|
2023
Q2 | $22.1K | Hold |
133,333
| – | – | ﹤0.01% | 46 |
|
|
2023
Q1 | $16K | Hold |
133,333
| – | – | ﹤0.01% | 55 |
|
|
2022
Q4 | $19.3K | Hold |
133,333
| – | – | ﹤0.01% | 54 |
|
|
2022
Q3 | $27K | Hold |
133,333
| – | – | 0.01% | 55 |
|
|
2022
Q2 | $37K | Buy |
+133,333
| New | +$85.8K | 0.01% | 56 |
|
Samsara BioCapital's NUVB.WS Position: Q1 2026 in Review
Samsara BioCapital sold out of Nuvation Bio Inc Warrants (NUVB.WS) in Q1 2026, closing a stake of 124,119 shares — an estimated $41K sold.
Samsara BioCapital first reported a position in NUVB.WS in Q2 2022 and held it in 15 quarters. The position peaked at $42.7K in Q1 2025. 0 funds tracked by Wall St. Rank hold NUVB.WS as of Q1 2026.
- Samsara BioCapital reported no remaining Nuvation Bio Inc Warrants position as of Q1 2026 after selling out during the quarter.
- Samsara BioCapital sold 124,119 Nuvation Bio Inc Warrants shares in Q1 2026, an estimated $41K.
- Samsara BioCapital first reported a position in Nuvation Bio Inc Warrants in Q2 2022 and held it in 15 quarters.
- Samsara BioCapital's Nuvation Bio Inc Warrants position peaked at $42.7K in Q1 2025.
- 0 funds tracked by Wall St. Rank held Nuvation Bio Inc Warrants as of Q1 2026.
Based on Samsara BioCapital's 13F filing for Q1 2026, filed 15 May 2026.